Additional drug-gene interactions were observed for APEX1 (Apurinic/Apyrimidinic Endodeoxyribonuclease 1) and N04 drug classification, which comprises of anti-Parkinson drugs, and includes anticholinergic and dopaminergic agents. This evidence concerns the gene APEX1 and Parkinsonism.